Podcast Summary: “Most Fraught” FOMC Meeting, Weight Loss Wars, and Sweet on Hershey’s

Podcast: The Exchange – CNBC
Date: September 16, 2025
Host(s): Melissa Lee, Mike Santoli

Overview

This episode of "The Exchange" covers an exceptionally tense prelude to the Federal Reserve's FOMC meeting, explores rapid developments in the weight loss drug sector, and examines bullish movements in gold, tech hardware, and consumer staples like Hershey's. The hosts offer both big-picture economic context and deep dives, featuring guest analysts on the Fed’s decision, tech hardware, pharma innovation, and the ongoing AI talent wars.

Key Segments and Insights

1. Market Conditions Ahead of FOMC Meeting

[00:59–05:08]

• Market Setup:

  • Stocks drifted slightly lower ahead of the Fed's highly anticipated rate decision; S&P and Nasdaq touched all-time highs, then retreated.
  • Gold surged, up over 40% YTD, defying typical correlations with inflation and monetary policy.
  • The US dollar hit multi-month lows, and bond yields remained firm, with the 10-year Treasury hovering just below 4%.

• Commentary:

  • High market certainty about a 25 bps cut raises risk of "sell the news" disappointment.
  • Consumer data (retail sales, credit card spending) looks constructive, but inflation adjustments and possible advance purchases cloud the full picture.

“We have this excess of certainty about what's about to happen. Sometimes when prices are higher, it creates room for disappointment.”
— Mike Santoli [02:12]

2. Deep Dive: The Most Fraught FOMC Meeting in 40 Years

[14:20, 27:25–36:16]

Guest: Paul McCulley, Former PIMCO Chief Economist

• Political and Economic Tension:

  • Intense political pressure surrounds the Fed; President Trump is publicly lobbying for aggressive rate cuts and in conflict with FOMC members.
  • Senate confirmation of Trump’s pick Stephen Myron, and possible challenges to Fed independence.

• Probability and Rationale for Rate Cuts:

  • Consensus among market participants (and McCulley) is for a 25 bps cut now, with a path toward a total of 100 bps in reductions.
  • McCulley: The real risk is the Fed’s current stance is 100 bps too high; this “recalibration” is needed now.
  • Dovish “dot plot” likely—two more cuts projected this year and more in 2026.

“This is really fraught with all of the political noise... but the irony is that strictly as an economic matter, this is a really easy decision.”
— Paul McCulley [30:33]

• Market Narrative:
  • Even if the Fed’s cuts guidance falls short at the press conference, many see volatility as a buying opportunity, assuming dovish policy regardless due to changing Fed membership.
  • Indicators point to a recalibration on policy, with Governor Waller's views increasingly influential within the committee.

“We need to get from here to here, because we're in the wrong neighborhood. And we're going to do it with dispatch.”
— Paul McCulley [34:42]

3. Tariffs, Inflation, and Federal Reserve Dilemmas

[27:25–29:02]

• Tariff-Driven Uncertainty:
  • CNBC survey: 86% of respondents see more price increases from tariffs ahead.
  • Who bears the burden? Primarily consumers (31%), wholesalers/importers (29%), with some load on retailers and exporters.
  • Respondents split on whether tariffs’ effects are transient or lead to lasting inflation.

“One side focused on the soft jobs number, the other on higher inflation fueled by tariff price increases that could have further to run.”
— Steve Liesman [28:53]

4. Tech Hardware Surge and the "Intelligence Revolution"

[16:16–23:22]

Guest: Mark Newman, Senior Analyst, Bernstein

• Bullish Calls on IT Hardware:
  • Bernstein initiated coverage with Outperform on Apple, Dell, SanDisk, and Seagate, citing AI-driven demand.
  • Seagate highlighted as top pick due to “hammer” tech advances; EPS CAGR estimated at 28% over 5 years.
  • SanDisk considered undervalued despite spin-out; strong upside from data storage and AI trends.
  • Apple seen as a long-term winner due to ecosystem and potential in AI, despite recent underperformance and concerns about innovation lag.
  • On IBM: Strong quantum leadership, but neutral call due to the timeline (real breakthrough seen closer to 2030).

“There's this real data explosion going on right now. Data needs to be stored so all the storage names... benefit from this.”
— Mark Newman [17:06]

5. AI Talent Wars: OpenAI vs. XAI/Musk

[41:56–43:42]

• Executive Moves:
  • OpenAI hires Mike Liberatore, ex-XAI CFO, to help manage massive infrastructure and AI ambitions, days after signing a $300B deal with Oracle.
  • Highlights the intensity of data center and executive competition, with Musk's XAI suffering high-profile departures.

“The switch underscores where the AI race is being fought right now: data centers and talent.”
— Mackenzie Segalos [43:01]

6. Pharma & Weight Loss Drug Wars

[37:09–41:54]

Guest: Angelica Peebles

• Novo Nordisk:
  • Stock surges on promising trial data for Cagralinotide (new hormone-based weight loss drug) and possibility of higher-dose Wegovy FDA approval.
  • Tolerability and side effect profiles emphasized as key competitive factors.
• Eli Lilly:
  • Announcing major US-based facilities to manufacture advanced therapies; investments driven by post-tax reform environment rather than tariffs.
  • CEO David Ricks: US tax changes major driver for reshoring production, aiming for both capacity growth and (gradually) bringing some European production to the US.
  • Oral obesity drug (orphaglipron) fast-track approval discussed, but CEO confirms nothing imminent yet.

“Right now for Novo, it's all about: can they advance their pipeline and show they're competitive into the next few years, into the next decade beyond Wegovy?”
— Angelica Peebles [37:41]

“We went 40 years without building an API site in the US because corporate tax rates were at 35%. Now… it makes more sense to build in the US than ever before.”
— David Ricks, Eli Lilly CEO [39:30]

7. Rapid Fire: Banks, Berkshire, and Hershey’s

[43:42–46:23]

• Bulge Bracket Banks:
  • Wells Fargo ups earnings forecasts for Citi, JP Morgan, Goldman, BofA, Morgan Stanley, citing deregulation, scale effects.
• Berkshire Hathaway:
  • Expected to lose >$3B in annual interest income if aggressive Fed cuts materialize, due to heavy T-bill holdings.
• Hershey's:
  • Goldman Sachs flips from "Sell" to "Buy" after headwinds from cocoa, tariffs, and weight loss drugs priced in.

Notable Quotes

• On Bubbles:
  “Frankly, Melissa, when I get concerned is when people actually start thinking that it isn't going to be a bubble… that kind of complacency is what we've seen at peaks like 1999, 2000.”
  — Julian Emanuel, Evercore ISI [07:57]

• On Gold’s Surprising Run:
  “Now gold is working for other reasons. Its momentum, its diversification away from dollar assets… it’s just working. Don’t ask why!”
  — Mike Santoli [25:22]

Timestamps of Key Segments

• [00:59–05:08] – Market setup before FOMC, retail sales, inflation context
• [05:08–10:43] – Analyst Julian Emanuel on market, rate cuts, bubbles
• [10:53–14:20] – Political backdrop: Trump’s UK trip & US business deals
• [16:16–23:22] – Tech hardware “Intelligence Revolution” with Bernstein’s Mark Newman
• [27:25–36:16] – FOMC deep dive with Paul McCulley; Fed politics, dovish case, dot plot
• [37:09–41:54] – Weight loss drugs: Novo Nordisk & Eli Lilly, pharma pipeline and reshoring
• [41:56–43:42] – AI talent wars, OpenAI vs. XAI, infrastructure push
• [43:42–46:23] – Rapid Fire: banks, Berkshire, Hershey’s & GS call

Memorable Moments

• McCulley’s Direct Take on Fed Policy:
  "They're about 100 basis points too high relative to neutrality. So they need to do a recalibration 2.0." — [30:33]
• Angelica Peebles summarizing the weight loss drug landscape:
  “Maybe it's not the best weight loss we've ever seen, but it's more tolerable—if you can make something that’s more tolerable, that could help.” — [38:43]
• Mike Newman on AI’s impact in hardware:
  “Data needs to be stored so all the storage names... benefit from this. But the real kicker... is the technology.” — [17:06]
• Trump on Fed Independence:
  "It should be [independent]. But I think they should listen to smart people like me... I got it right." — [29:32]

Conclusion

This densely packed episode crystallizes pre-Fed suspense in unusually politicized circumstances, offers expert forecasts on rates, breaks down the hot race in AI and tech hardware, and highlights seismic shifts in health and consumer sectors. Strategic quotes and granular analysis make this a resourceful listen for those wanting the pulse on policy, macro, tech, and market movers right now.